Literature DB >> 11492992

Long-term follow-up of children and adolescents with syncope; predictor of syncope recurrence.

C Kouakam1, G Vaksmann, E Pachy, D Lacroix, C Rey, S Kacet.   

Abstract

BACKGROUND: Previous studies have shown that investigation by tilt testing is very appropriate in paediatrics, but the characteristics of children and adolescents who are at high risk of recurrent syncope, once the diagnosis is established, remain unclear. This study was set up to analyse the risk factors attributed to syncope recurrence in paediatric patients.
METHODS: One hundred and one children and adolescents aged 7 to 18 years, undergoing a tilt test for recurrent syncope, were studied. They were subsequently followed-up in clinic visits with a final interview at the clinic or by telephone at the end of the follow-up period.
RESULTS: A head-up tilt test elicited syncope or pre-syncope in 67 children. The positive responses included vasovagal syncope in 58 patients and psychogenic syncope in nine patients. Gender, age, number of pre-tilt test syncopal episodes or duration of symptoms made no difference to children with positive or negative tilt test results. Following the tilt test, 43 of 67 children with a positive tilt test were treated empirically. No treatment was prescribed for the remaining 24 with a positive test, or for those with a negative tilt test. There were no differences between treated and untreated children with respect to the number of pre-tilt test syncopes, duration of symptoms and duration of follow-up. Follow-up data were available in 97 children. During a mean follow-up of 46+/-28 months, syncope recurred in 31 children (32%). The recurrence rate was similar between positive and negative tilt test groups (22/66 vs 9/31, respectively; P=ns), as well as between treated and untreated children (14/43 vs 8/23, respectively; P=ns). When comparing syncope-free children at follow-up in a univariate analysis, children with recurrent syncope reported a greater number of historical syncopal spells (7+/-8 vs 3+/-3, P=0.01). In addition linear correlation (r=0.6, 95% CI 0.47 to 0.72, P<0.0001) was significant between the number of historical syncope episodes and the risk of recurrent syncope.
CONCLUSIONS: These findings suggest that the risk of syncope recurrence for children and adolescents with such a history is not correlated to the tilt test result or prophylactic treatment. The number of historical syncopal spells is, however, predictive. Copyright 2001 The European Society of Cardiology.

Entities:  

Mesh:

Year:  2001        PMID: 11492992     DOI: 10.1053/euhj.2000.2577

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  12 in total

1.  Long-term follow-up of patients with syncope evaluated by head-up tilt test.

Authors:  Giulia Domenichini; Igor Diemberger; Mauro Biffi; Cristian Martignani; Cinzia Valzania; Matteo Bertini; Davide Saporito; Matteo Ziacchi; Angelo Branzi; Giuseppe Boriani
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-04       Impact factor: 1.468

Review 2.  Key challenges in the current management of syncope.

Authors:  Richard Sutton; Michele Brignole; David G Benditt
Journal:  Nat Rev Cardiol       Date:  2012-07-17       Impact factor: 32.419

Review 3.  Loss of Consciousness in the Young Child.

Authors:  Juan Villafane; Jacob R Miller; Julie Glickstein; Jonathan N Johnson; Jonathan Wagner; Chris S Snyder; Tatiana Filina; Scott L Pomeroy; S Kristen Sexson-Tejtel; Caitlin Haxel; Jason Gottlieb; Pirooz Eghtesady; Devyani Chowdhury
Journal:  Pediatr Cardiol       Date:  2021-01-02       Impact factor: 1.655

4.  Cost of Unnecessary Testing in the Evaluation of Pediatric Syncope.

Authors:  Connor Redd; Cameron Thomas; Martha Willis; Michelle Amos; Jeffrey Anderson
Journal:  Pediatr Cardiol       Date:  2017-05-18       Impact factor: 1.655

Review 5.  Current approaches to the clinical assessment of syncope in pediatric population.

Authors:  Ayşe Kaçar Bayram; Ozge Pamukcu; Huseyin Per
Journal:  Childs Nerv Syst       Date:  2016-01-05       Impact factor: 1.475

6.  Comparison of recurrence rate based on the frequency of preceding symptoms in patients with neurocardiogenic syncope or presyncope.

Authors:  Seon Mee Lee; Hye Lim Oh; June Soo Kim; Jungwae Park; Hye Ran Yim; Dae Hee Shin; Young Keun On; Sang Hoon Lee
Journal:  Korean Circ J       Date:  2011-08-31       Impact factor: 3.243

7.  Positive result in the early passive phase of the tilt-table test: a predictor of neurocardiogenic syncope in young men.

Authors:  Jae-Sun Uhm; Ho-Joong Youn; Woo-Baek Chung; Yun-Seok Choi; Chul-Soo Park; Yong-Seog Oh; Wook-Sung Chung; Kyung-Il Park; Tae-Suk Kim
Journal:  Korean J Intern Med       Date:  2012-02-28       Impact factor: 2.884

8.  Unexplained Syncope and Diagnostic Yield of Tests in Syncope According to the ICD-10 Discharge Diagnosis.

Authors:  Martin Huth Ruwald; Morten Lock Hansen; Morten Lamberts; Michael Vinther; Christian Torp-Pedersen; Jim Hansen; Gunnar Hilmar Gislason
Journal:  J Clin Med Res       Date:  2013-10-12

9.  Nonpharmacologic Treatments Alone are Enough to Prevent the Neurally Mediated Syncope: A 3 Years Follow-up Study.

Authors:  Bahar Dehghan; Mohammad Reza Sabri; Marjan Mansourian
Journal:  Int J Prev Med       Date:  2019-05-17

10.  Poincaré Plot Can Be a Useful Tool to Select Potential Responders to Metoprolol Therapy in Children with Vasovagal Syncope.

Authors:  Piaoliu Yuan; Xueying Li; Chunyan Tao; Xiaojuan Du; Chunyu Zhang; Junbao Du; Yaqian Huang; Ying Liao
Journal:  Int J Gen Med       Date:  2022-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.